The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.

导出 OA

翻译打印收藏纠错

作者： Jessica R,Galloway-Peña ^[1] ; Daniel P,Smith ^[2] ; Pranoti,Sahasrabhojane ^[1] ; Nadim J,Ajami ^[2] ; W Duncan,Wadsworth ^[3] ; Naval G,Daver ^[4] ; Roy F,Chemaly ^[5] ; Lisa,Marsh ^[1] ; Shashank S,Ghantoji ^[1] ; Naveen,Pemmaraju ^[1] ; Guillermo,Garcia-Manero ^[5] ; Katayoun,Rezvani ^[5] ; Amin M,Alousi ^[6] ; Jennifer A,Wargo ^[6] ; Elizabeth J,Shpall ^[7] ; Phillip A,Futreal ^[8] ; Michele,Guindani ^[6] ; Joseph F,Petrosino ^[8] ; Dimitrios P,Kontoyiannis ^[3] ; Samuel A,Shelburne ^[2]

作者单位： Department of Infectious Disease, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[1] The Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas. ^[2] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[3] Department of Statistics, Rice University, Houston, Texas. ^[4] Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[5] Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[6] Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[7] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. ^[8]

关键词 acute myeloid leukemia gastrointestinal induction chemotherapy infectious complications microbiome